Care you should take with low blood sugar

Diabetes is a serious disease that endangers human health in many ways. Due to diabetes, the sugar levels rise so much that they endanger many organs.

However, the other side of diabetes has to do with the very low level of sugar in the blood, causing what is known as hypoglycemia.

The presence of the latter can cause disorientation, weakness, contractions and in some cases even premature death.

According to experts, intensive treatment with medications and insulin can be a strong reason for the rapid decrease in blood sugar levels.

From a review of the analyzes of all 10.2 million diabetics from 2011 to 2014, various experts have learned that 2.3 million of them had overdosed on medications.

10,000 of them suffered some hypoglycemia as a result of glucose-lowering therapies.

Hypoglycemia can affect people with type 1 diabetes (when the body does not produce insulin) and type 2 diabetes (when the body produces but not enough insulin.)

In 95 percent of cases, people suffer from type 2 diabetes.

What are the proper blood sugar levels?

Normal blood sugar levels range from 80 to 120 mg/dl before meals and less than 180 mg/dl after meals.

In cases of hypoglycemia, blood sugar levels fall below 70 mg/dl.

Shortages of insulin on the market put patients at risk

Many diabetics in the world fail to receive proper treatment due to lack of insulin.

Scientists predict that the amount of insulin needed to treat diabetes will increase by more than twenty percent by 2030.

In the same year, it is expected that the number of diabetics will reach approximately 510 million people in the world.

On the other hand, they expect that access to insulin will continue to be limited, endangering the lives of millions of people, especially in Asia and Africa.

Insulin is an almost 100-year-old drug and has been described as one of the most miraculous drugs of the twentieth century.

Its price continues to remain high for a strong reason. 99 percent of global insulin production, according to BBC, is controlled by three companies: Novo Nordisk, Eli Lilly and Sanofi.

The demand for insulin on the black market is extremely high and has increased by 10 percent in 90 years.

The price of a bottle in many countries of the world ranges from $40 to $130.

In the United States it can reach over $300. This fee forces many diabetics to obtain the necessary drugs in Canada. /AgroWeb/